IDENTIFYING AND APPRAISING FIT-FOR-PURPOSE DATA SOURCES FOR REAL WORLD EVIDENCE STUDIES: A STRUCTURED APPROACH TO CONDUCTING DATA SOURCE FEASIBILITY ASSESSMENTS

被引：0
|
作者：
Matthews, H. [1 ]
Alexander, M. [1 ]
Glen, F. [1 ]
机构：
[1] Open Hlth, Marlow, Bucks, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD105
引用
收藏
页码：S524 / S524
页数：1
相关论文
共 14 条
  • [1] The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework
    Gatto, Nicolle M.
    Campbell, Ulka B.
    Rubinstein, Emily
    Jaksa, Ashley
    Mattox, Pattra
    Mo, Jingping
    Reynolds, Robert F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 122 - 134
  • [2] A Structured Process to Identify Fit-for-Purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory Uses
    Gatto, Nicolle M. M.
    Vititoe, Sarah E. E.
    Rubinstein, Emily
    Reynolds, Robert F.
    Campbell, Ulka B. B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (06) : 1235 - 1239
  • [3] Identifying fit-for-purpose existing data sources for COVID-19 pre-exposure prophylaxis in pregnancy
    Boin, Elodie
    Davies, Jessica
    Lecomte, Coralie
    Lee, Andrew
    Kim, Joseph
    Druelles, Sophie
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 215 - 216
  • [4] Building fit-for-purpose real-world clinicogenomic data in aesthetics for personalized skin care goals
    Schneiderman, Chris
    Liu, Mengzhen
    Ukah, Ahunna
    Manson-Brown, Stephanie
    Peterson, Sherket
    Mehta, Rahul
    Waring, Jeff
    Thompson, Debora
    Barry, Dawn
    Liede, Alexander
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 434 - 434
  • [5] Real world evidence in rare disease-Application of fit for purpose data sources framework in portopulmonary hypertension
    Rosenberg, Daniel
    Van Baalen, Valerie
    Brand, Monika
    Didden, Eva-Maria
    Martin, Nicolas
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 552 - 553
  • [6] Assessing fit-for-purpose: Surrogate endpoints and clinically important outcomes in Japanese real-world data source in type-2 diabetes
    Wang, Jocelyn Ruoyi
    Patrick, Amanda
    Mattox, Pattra
    Jaksa, Ashley
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 593 - 593
  • [7] Characterizing fit-for-purpose real-world data: An assessment of a mother-infant linkage in the Japan medical data center claims database
    Barberio, Julie
    Hernandez, Rohini K.
    Naimi, Ashley I.
    Patzer, Rachel E.
    Kim, Christopher
    Lash, Timothy L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 613 - 614
  • [8] Characterizing Fit-for-Purpose Real-World Data: An Assessment of a Mother-Infant Linkage in the Japan Medical Data Center Claims Database
    Barberio, Julie
    Hernandez, Rohini K.
    Naimi, Ashley, I
    Patzer, Rachel E.
    Kim, Christopher
    Lash, Timothy L.
    [J]. CLINICAL EPIDEMIOLOGY, 2024, 16 : 31 - 43
  • [9] ASSESSMENT OF REAL-WORLD DATA SOURCES AND A HYBRID APPROACH IN REAL-WORLD EVIDENCE GENERATION USING UNHARMONIZED DATA SOURCES
    Toh, K. C.
    Goh, C. H.
    Goh, V
    Dong, Z.
    Dumpala, L. S.
    Maity, S.
    Wu, J. Y.
    Kleinman, N.
    Lee, Y.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S407 - S407
  • [10] FROM CLINICAL TRIAL TO REAL-WORLD EVIDENCE: A SYSTEMATIC APPROACH TO IDENTIFYING DATA SOURCES FOR OBSERVATIONAL RESEARCH
    Parasuraman, B.
    Tomic, K. S.
    Winchester, C. C.
    Westergaard, M.
    Johansson, S.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A583 - A584
12